Abstract: Introduction: In current clinical practice, obstructive coronary artery disease (CAD) remains the most common underlying cause of heart failure with reduced ejection fraction (HFrEF), with many of these patients having a history of myocardial infarction (MI) or revascularization. Despite advances in cardiovascular diseases, chronic heart failure (HF) is a category, which the prevalence, incidence, hospitalization rate, total burden of mortality, and costs have increased in the past 2-3 decades. Even though HF is a major global health problem, the data from developing countries are sparse.....
Keywords: Coronary Artery Disease, Heart Failure, Ejection Fraction
[1]. P. Ponikowski, A.A. Voors, S.D. Anker, Et Al. 2016 Esc Guidelines For The Diagnosis And Treatment Of Acute And Chronic Heart Failure: The Task Force For The Diagnosis And Treatment Of Acute And Chronic Heart Failure Of The European Society Of Cardiology (Esc) Developed With The Special Contribution Of The Heart Failure Association (Hfa) Of The Esc Eur Heart J, 37 (2016), Pp. 2129-2200
[2]. G.J.R. Tenkate, K. Caliskan, A. Dedic, Et Al. Computed Tomography Coronary Imaging As A Gatekeeper For Invasive Coronary Angiography In Patients With Newly Diagnosed Heart Failure Of Unknown Aetiology Eur J Heart Fail, 15 (2013), Pp. 1028-1034
[3]. A. Levi, T. Bental, A.R. Assali, Et Al. Dynamic Changes In Left Ventricular Function After A Percutaneous Coronary Intervention: Prevalence, Predictors, And Prognosis Coron Artery Dis, 27 (2016), Pp. 199-206
[4]. Yancy Cw, Jessup M, Bozkurt B, Et Al. 2013 Accf/Aha Guideline For The Management Of Heart Failure: A Report Of The American College Of Cardiology Foundation/American Heart Association Task Force On Practice Guidelines. J Am Coll Cardiol. 2013; 62(16):E147-239.
[5]. Blair Je, Zannad F, Konstam Ma, Et Al. Continental Differences In Clinical Characteristics, Management, And Outcomes In Patients Hospitalized With Worsening Heart Failure Results From The Everest (Efficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan) Program. J Am Coll Cardiol. 2008; 52(20):1640-8.